Publications

August 2009 (Revised April 2012)
Case

Genzyme's CSR Dilemma: How to Play its HAND

By: Christopher A. Bartlett, Tarun Khanna and Prithwiraj Choudhury

Genzyme, a global biotechnology company, launches a program to develop therapies for neglected diseases (e.g., malaria, TB), giving away the intellectual property. This case focuses on the decision of which diseases, which partnerships, and which markets should... View Details

Keywords: Global Strategy; Health Care and Treatment; Intellectual Property; Corporate Social Responsibility and Impact; Partners and Partnerships; Research and Development; Biotechnology Industry

19 Dec 2016
Blog Post

The Making of An Internship: Impact

influence an organizations’ success longterm. Watch as three Class of 2017 students highlight the projects they worked on during their summer internships, and the impacts they made. Francesca Ioffreda created the business case for a new digital innovation platform at... View Details

Keywords: All Industries

31 Mar 2023
Blog Post

Bring your authentic self to work: Advice from HBS alumni

felt the most affirmed and championed when my team has seen my distinct lived experience as an asset, not just an advertisement opportunity. Social Finance did just that and allowed me to leverage my queer identity and global health... View Details

Keywords: All Industries

2014
Working Paper

Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms

By: Prithwiraj Choudhury and Tarun Khanna

Since the 1990s, several Western firms have filed patents based on medicinal herbs from emerging markets, evoking protests from local stakeholders against 'bio-piracy'. We explore conditions under which firms and local stakeholders share rents from such patents. Our... View Details

Keywords: Rents From New Technology; Local Stakeholders; Herbal Patents; QCA; Fuzzy Set Analysis; Qualitative Case Studies; Plant-Based Agribusiness; Patents; Emerging Markets; Health Care and Treatment; Business and Stakeholder Relations; Cross-Cultural and Cross-Border Issues; Agriculture and Agribusiness Industry; Agriculture and Agribusiness Industry

Read Now

January 2025
Supplement

Wendell Weeks at Corning Inc.

By: Ryan Raffaelli

Keywords: Innovation and Invention; Innovation Strategy; Technological Innovation; Disruptive Innovation; Information Technology; Leadership; Health Pandemics; Technology Industry; United States; New York (city, NY)

01 Aug 1998
News

A Roaring Success in the Windy City

H. Stevenson, for instance, discussed the evolution of the field of entrepreneurship at HBS and beyond. Professor Malcolm S. Salter addressed "Facing the Modern Industrial Revolution," focusing on the tools established companies can use... View Details

31 Mar 2023
Blog Post

How to Come Out at Work

felt the most affirmed and championed when my team has seen my distinct lived experience as an asset, not just an advertisement opportunity. Social Finance did just that and allowed me to leverage my queer identity and global health... View Details

06 Dec 2021
News

Monaco's Digital Transformation

Genta manages 5 percent of the state budget and a staff of 270. His ministry oversees the telecom industry and digital improvements in smart city initiatives, education, and health care, as well as programs... View Details

Keywords: Jennifer Gillespie

Web

3 Technologies that Will Change the World - Course Catalog

in the justice system and the industrialization of misinformation and hacking of elections. How can business leaders create great companies that enhance the value to society while earning a return for shareholders? Blockchain – Changing... View Details

2024
Article

Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway

By: Mateo Aboy, Cristina Crespo and Ariel Stern

Moderate-risk medical devices constitute 99% of those that have been regulated by the U.S. Food and Drug Administration (FDA) since it gained authority to regulate medical technology nearly five decades ago. This article presents an analysis of the interaction between... View Details

Keywords: Governing Rules, Regulations, and Reforms; Health Care and Treatment; Technology Adoption; Technological Innovation; Safety; Medical Devices and Supplies Industry; United States

Read Now

01 Apr 2000
News

Real World Issues Aired at Student Led Conferences

Always impressive, the annual conferences organized by HBS student clubs bring together industry leaders, alumni, and students for meetings marked by informative discussions of key business issues. Earlier this year, gatherings sponsored... View Details

Keywords: Mary Ellen Gardner

14 Apr 2022
Blog Post

Trust the Process, and Trust Yourself Even More: Interview with Wellness and Empowerment Leader, Dilan Gomih (MBA 2019)

Professional Development who gave her a sounding board and new perspective, and ultimately decided to make the scary but exciting jump back into the industry she loved. Her next role was as the Director of Strategic Initiatives at... View Details

Summer 2020
Article

Is It Time to Rethink Globalized Supply Chains?: The COVID-19 Pandemic Should Be a Wake-up Call for Managers and Prompt Them to Consider Actions That Will Improve Their Resilience to Future Shocks

By: Willy C. Shih

The COVID-19 pandemic has exposed the complex interdependencies of globalized supply chains. While these global multistage production networks had spread during a relatively benign environment of falling trade barriers and increasing interdependencies among countries,... View Details

Keywords: Supply Chains; Pandemic; Resilience; Supply Chain Management; Supply Chain; Global Range; Health Pandemics; Disruption; System Shocks; Crisis Management; Manufacturing Industry; United States; Asia; Europe; China

Find at Harvard

Register to Read

August 2008 (Revised May 2009)
Background Note

Note on Generic Drugs in the European Union

By: Robert C. Pozen and Elizabeth M. Leonard

Rules governing the introduction of generic drugs in U.S. and EU have some similarities but significant differences because of the Hatch-Waxman Act in the U.S. View Details

Keywords: Governing Rules, Regulations, and Reforms; Government Legislation; Health Care and Treatment; Trademarks; Brands and Branding; Pharmaceutical Industry; European Union; United States

Find at Harvard

August 2001
Case

Scios, Inc.

By: Regina E. Herzlinger

Scios, filled with distinguished scientists and experienced managers, nevertheless fails to clear the FDA Phase III process for an important biotechnology drug. This case asks the students to analyze the social costs and benefits of the regulatory process. View Details

Keywords: Governing Rules, Regulations, and Reforms; Health Care and Treatment; Cost Management; Cost vs Benefits; Social Issues; Pharmaceutical Industry; United States

Profile

Henry McCance

discovered three of the four then-known genes associated with Alzheimer’s. “Part of my skill set is I can recognize world-class talent when I see it,” says McCance. “I knew he was the kind of guy Greylock would have backed if he had chosen the software View Details

Keywords: Health Care; Health Care; Health Care

February 1998 (Revised October 1998)
Background Note

Note on New Drug Development in the United States

By: Stefan H. Thomke and Ashok Nimgade

An overview of the new drug development process in the United States, using the migraine drug Imitrex as an illustrative example. View Details

Keywords: Product Development; Research and Development; Health; Pharmaceutical Industry; United States

10 Mar 2015
News

Women in Tech: Breaking the Digital Ceiling

fashion e-commerce company, Peach. It’s also a challenge to an industry where a company’s potential is often predicted based on its similarity to other successful ventures, most often led by CEOs who look a whole lot like Mark Zuckerberg.... View Details

Keywords: April White

February 2016
Case

Express Scripts: Promoting Prescription Drug Home Delivery (A)

By: John Beshears, Patrick Rooney and Jenny Sanford

The pharmacy benefit manager (PBM) sector processes prescription drug claims on behalf of companies that offer a prescription drug benefit to their employees. This case follows Bob Nease, Chief Scientist at Express Scripts, as he considers methods to promote home... View Details

Keywords: Pharmaceuticals; Prescription Drugs; Pharmacy Benefit Manager; PBM; Healthcare; Behavioral Economics; Choice Architecture; Active Choice; Service Delivery; Decision Choices and Conditions; Health Care and Treatment; Order Taking and Fulfillment; Compensation and Benefits; Pharmaceutical Industry